Alliance Pharma Adjourns Meetings for Acquisition Discussions

The latest announcement is out from Alliance Pharma ( (GB:APH) ).

Alliance Pharma PLC has announced an adjournment of its Court and General Meetings regarding the acquisition by Aegros Bidco Limited, a company indirectly owned by DBAY Affiliates and the ERES IV Fund. This delay is intended to provide more time for discussions with shareholders and for them to consider the acquisition terms. The meetings are rescheduled for March 13, 2025, and this move indicates the company’s effort to ensure shareholder alignment and transparency in the acquisition process.

More about Alliance Pharma

YTD Price Performance: 36.61%

Average Trading Volume: 4,610,632

Technical Sentiment Consensus Rating: Sell

Current Market Cap: £337.9M

For an in-depth examination of APH stock, go to TipRanks’ Stock Analysis page.